CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments

1.3.1. List of players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Clinical trials
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase in funding for improved dialysis products and services
3.4.1.2. Increase in the number of ESRD patients
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation

3.4.2. Restraints

3.4.2.1. Risks and complications associated with dialysis
3.4.2.2. Product recall

3.4.3. Opportunities

3.4.3.1. Technological advancements leading to better adoption
3.4.3.2. Growth opportunities in emerging economies

3.4.4. Impact Analyses

3.5. Patent analysis (2013-2018)

3.5.1. Patent analysis, by year

CHAPTER 4: HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES

4.1. Overview

4.1.1. Market size and forecast

4.2. Equipment

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Dialysis Machines

4.2.3.1. Market size and forecast

4.2.4. Hemodialysis Water Treatment Systems

4.2.4.1. Market size and forecast

4.2.5. Others hemodialysis equipment

4.2.5.1. Market size and forecast

4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country

4.3. Consumables

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.3. Dialyzers

4.3.3.1. Market size and forecast

4.3.4. Catheters

4.3.4.1. Market size and forecast

4.3.5. Other hemodialysis consumables

4.3.5.1. Market size and forecast

4.3.6. Market size and forecast, region
4.3.7. Market analysis, by country

4.4. Drugs

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Services

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5: HEMODIALYSIS MARKET, BY TYPE

5.1. Overview
5.2. Conventional hemodialysis

5.2.1. Market analysis, by country

5.3. Short daily hemodialysis/daily hemodialysis

5.3.1. Market analysis, by country

5.4. Nocturnal hemodialysis

5.4.1. Market analysis, by country

CHAPTER 6: HEMODIALYSIS MARKET BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. hemodialysis market, by type
6.2.2.1.2. U.S. hemodialysis market, by product and service
6.2.2.1.3. U.S. hemodialysis market, by end user

6.2.2.2. Canada

6.2.2.2.1. Canada hemodialysis market, by type
6.2.2.2.2. Canada hemodialysis market, by product and service
6.2.2.2.3. Canada hemodialysis market, by end user

6.2.2.3. Mexico

6.2.2.3.1. Mexico hemodialysis market, by type
6.2.2.3.2. Mexico hemodialysis market, by product and service
6.2.2.3.3. Mexico hemodialysis market, by end user

6.2.3. North America hemodialysis market, by type
6.2.4. North America hemodialysis market, by product and service
6.2.5. North America hemodialysis market, by end user

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany hemodialysis market, by type
6.3.2.1.2. Germany hemodialysis market, by product and service
6.3.2.1.3. Germany hemodialysis market, by end user

6.3.2.2. France

6.3.2.2.1. France hemodialysis market, by type
6.3.2.2.2. France hemodialysis market, by product and service
6.3.2.2.3. France hemodialysis market, by end user

6.3.2.3. UK

6.3.2.3.1. UK hemodialysis market, by type
6.3.2.3.2. UK hemodialysis market, by product and service
6.3.2.3.3. UK hemodialysis market, by end user

6.3.2.4. Italy

6.3.2.4.1. Italy hemodialysis market, by type
6.3.2.4.2. Italy hemodialysis market, by product and service
6.3.2.4.3. Italy hemodialysis market, by end user

6.3.2.5. Spain

6.3.2.5.1. Spain hemodialysis market, by type
6.3.2.5.2. Spain hemodialysis market, by product and service
6.3.2.5.3. Spain hemodialysis market, by end user

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe hemodialysis market, by type
6.3.2.6.2. Rest of Europe hemodialysis market, by product and service
6.3.2.6.3. Rest of Europe hemodialysis market, by end user

6.3.3. Europe hemodialysis market, by type
6.3.4. Europe hemodialysis market, by product and service
6.3.5. Europe hemodialysis market, by end user

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan hemodialysis market, by type
6.4.2.1.2. Japan hemodialysis market, by product and service
6.4.2.1.3. Japan hemodialysis market, by end user

6.4.2.2. China

6.4.2.2.1. China hemodialysis market, by type
6.4.2.2.2. China hemodialysis market, by product and service
6.4.2.2.3. China hemodialysis market, by end user

6.4.2.3. India

6.4.2.3.1. India hemodialysis market, by type
6.4.2.3.2. India hemodialysis market, by product and service
6.4.2.3.3. India hemodialysis market, by end user

6.4.2.4. Australia

6.4.2.4.1. Australia hemodialysis market, by type
6.4.2.4.2. Australia hemodialysis market, by product and service
6.4.2.4.3. Australia hemodialysis market, by end user

6.4.2.5. South Korea

6.4.2.5.1. South Korea hemodialysis market, by type
6.4.2.5.2. South Korea hemodialysis market, by product and service
6.4.2.5.3. South Korea hemodialysis market, by end user

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Rest of Asia-Pacific hemodialysis market, by type
6.4.2.6.2. Rest of Asia-Pacific hemodialysis market, by product and service
6.4.2.6.3. Rest of Asia-Pacific hemodialysis market, by end user

6.4.3. Asia-Pacific hemodialysis market, by type
6.4.4. Asia-Pacific hemodialysis market, by product and service
6.4.5. Asia-Pacific hemodialysis market, by end user

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil hemodialysis market, by type
6.5.2.1.2. Brazil hemodialysis market, by product and service
6.5.2.1.3. Brazil hemodialysis market, by end user

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia hemodialysis market, by type
6.5.2.2.2. Saudi Arabia hemodialysis market, by product and service
6.5.2.2.3. Saudi Arabia hemodialysis market, by end user

6.5.2.3. South Africa

6.5.2.3.1. South Africa hemodialysis market, by type
6.5.2.3.2. South Africa hemodialysis market, by product and service
6.5.2.3.3. South Africa hemodialysis market, by end user

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA hemodialysis market, by type
6.5.2.4.2. Rest of LAMEA hemodialysis market, by product and service
6.5.2.4.3. Rest of LAMEA hemodialysis market, by end user

6.5.3. LAMEA hemodialysis market, by type
6.5.4. LAMEA hemodialysis market, by product and service
6.5.5. LAMEA hemodialysis market, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Asahi Kasei Corporation.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance

7.2. B. Braun Melsungen AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Baxter International Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Cantel Medical Corp.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance

7.5. DaVita Inc.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Diaverum.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product Portfolio
7.6.4. Key strategic moves and developments

7.7. Fresenius Medical Care AG & Co. KGaA

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Nikkiso Co., Ltd.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Nipro Corporation

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. NxStage Medical, Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments